✦ LIBER ✦

Limb-threatening vascular disease in patients with coincidental malignancy. An approach to management

✍ Scribed by Russell H. Samson; Sushil K. Gupta; Larry A. Scher; Frank J. Veith

Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 218 KB
Volume: 52
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19830915)52:6<1126::aid-cncr2820520634>3.0.co;2-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An approach to the management of patient

An approach to the management of patients with residual Cushing’s disease

✍ Lewis S. Blevins; Nader Sanai; Sandeep Kunwar; Jessica K. Devin 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 183 KB

New approach to management of intraaorti

New approach to management of intraaortic balloon pumps in patients with peripheral vascular disease: Case reports of four patients requiring urgent IABP insertion

✍ Lewis, Bruce E. ;Sumida, Colin ;Hwang, Ming H. ;Loeb, Henry S. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB

Lung biopsy in immunocompromised patient

Lung biopsy in immunocompromised patients: One institution's experience and an approach to management of pulmonary disease in the compromised host

✍ Jeffrry P. Jaffe; Dennis G. Maki 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 1015 KB

41.8°C whole body hyperthermia as an adj

41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases

✍ Djordje Atanackovic; Axel Nierhaus; Michael Neumeier; Dieter K. Hossfeld; Susann 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 314 KB

Use of an intravascular thrombectomy dev

Use of an intravascular thrombectomy device to treat life-threatening venous thrombosis in a patient with Crohn's disease and G20210A prothrombin gene mutation

✍ G.S. Latzman; A. Kornbluth; S.J. Murphy; P. Legnani; J. George; J. Guller; S. Le 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis. 2006;65:398 -400. 7. Braun-Moscovici Y, Markovits D, Zinder O, et al. Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-a

Study of active controlled tocilizumab m

Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy

✍ Norihiro Nishimoto; Nobuyuki Miyasaka; Kazuhiko Yamamoto; Shinichi Kawai; Tsutom 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 250 KB